FDA NDC Directory · JSON-LD · Markdown

Divalproex Sodium

NDC 57237-106 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090554
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsDIVALPROEX SODIUM (125 mg/1)
Marketing started20141024
Package count2

External sources

Source: openFDA. Public-domain (CC0).